Yetunde Tagurum
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yetunde Tagurum has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Bradley J. Monk
Florida Cancer Specialists & Research Institute West Palm Beach Florida USA
1 shared publication- Chandni Patel
Florida Cancer Specialists & Research Institute Fort Myers Florida USA
1 shared publication Christina White
Florida Cancer Specialists & Research Institute Ocala Florida USA
1 shared publicationCrystal Clark
Florida Cancer Specialists & Research Institute Trinity Florida USA
1 shared publication- Gigi A. Gonzales
Florida Cancer Specialists & Research Institute Port Charlotte Florida USA
1 shared publication - Gustavo Fonseca
Florida Cancer Specialists & Research Institute Lecanto Florida USA
1 shared publication
Latest Publications
- Open Access
- 9 August 2026
- Published by Wiley in Psycho-Oncology
- Vol. 35 (8) , e70572
Understanding Cancer Clinical Trial Participation in Rural Communities: A Qualitative Focus Group Study
Background: Participation in cancer clinical trials is essential for advancing oncologic care, yet enrollment among rural populations remains disproportionately low. These communities face many hurdles including geographical distance from medical centers, healthcare workforce shortages, and deep‐seated medical mistrust that may contribute to survival inequities. Aims: To address these gaps, a Research Navigator program was launched through the Florida Cancer Specialists & Research Institute to engage rural Florida residents in focus group sessions to identify barriers to trial participation. Methods: Utilizing the Integrated Behavioral and Socioecological Framework (IBSF), the study conducted five semi‐structured focus groups with 30 participants recruited from rural Florida counties. Participants included cancer survivors, advocates, caregivers, and those currently in treatment. Discussions centered on knowledge, experiences, perceived barriers, and willingness to participate in cancer clinical trials. Results: Although most participants expressed awareness of cancer clinical trials, focus group discussions revealed misconceptions regarding trial purpose, process, and accessibility. Across groups, commonly reported barriers to participation included limited access to reliable transportation, financial concerns, and mistrust of medical professionals and healthcare systems. Thematic analysis of focus group transcripts yielded four themes: (A) perception and lived experience, (B) trial information dissemination, (C) enrollment impediments, and (D) intervention strategies and implementation. Conclusion: In rural settings, decisions regarding cancer clinical trial participation are shaped by a complex interplay of trust, logistics, and information access. This study emphasizes the importance of viewing trials as routine care and suggests that navigator‐led outreach and patient‐centric technology are essential for creating equitable access.
- 9 August 2026
- Published by Wiley in Psycho-Oncology
- Vol. 35 (8) , e70572
Open AccessUnderstanding Cancer Clinical Trial Participation in Rural Communities: A Qualitative Focus Group Study
Background: Participation in cancer clinical trials is essential for advancing oncologic care, yet enrollment among rural populations remains disproportionately low. These communities face many hurdles including geographical distance from medical centers, healthcare workforce shortages, and deep‐seated medical mistrust that may contribute to survival inequities. Aims: To address these gaps, a Research Navigator program was launched through the Florida Cancer Specialists & Research Institute to engage rural Florida residents in focus group sessions to identify barriers to trial participation. Methods: Utilizing the Integrated Behavioral and Socioecological Framework (IBSF), the study conducted five semi‐structured focus groups with 30 participants recruited from rural Florida counties. Participants included cancer survivors, advocates, caregivers, and those currently in treatment. Discussions centered on knowledge, experiences, perceived barriers, and willingness to participate in cancer clinical trials. Results: Although most participants expressed awareness of cancer clinical trials, focus group discussions revealed misconceptions regarding trial purpose, process, and accessibility. Across groups, commonly reported barriers to participation included limited access to reliable transportation, financial concerns, and mistrust of medical professionals and healthcare systems. Thematic analysis of focus group transcripts yielded four themes: (A) perception and lived experience, (B) trial information dissemination, (C) enrollment impediments, and (D) intervention strategies and implementation. Conclusion: In rural settings, decisions regarding cancer clinical trial participation are shaped by a complex interplay of trust, logistics, and information access. This study emphasizes the importance of viewing trials as routine care and suggests that navigator‐led outreach and patient‐centric technology are essential for creating equitable access.